Dechra Pharmaceuticals PLC
DCHPF · OTC
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Market Cap | $4 | $3 | $5 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | $4 | $4 | $5 | $3 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 11.7% | 12.1% | 18% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 56% | 56.4% | 56.9% | 56.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 11.4% | 26.2% | 26.6% | 25.4% |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -3.7% | 8.5% | 9.1% | 6.6% |
| EPS Diluted | -0.24 | 0.53 | 0.51 | 0.33 |
| % Growth | -145.3% | 3.9% | 54.5% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |